摘要
原发性胆汁性胆管炎(primary biliary cholangitis,PBC)是一种病因不明的自身免疫性胆汁淤积性肝病,部分患者常出现顽固性瘙痒及严重的高胆红素血症,目前临床上药物治疗有限,晚期并发症多,预后差,严重影响患者生存质量。当前,可暂时替代肝脏部分功能的非生物型人工肝治疗模式在临床上广泛应用,但应用非生物性人工肝治疗PBC患者的研究甚少,现将国内外相关研究进展综述如下。
Primary Biliary Cholangitis(PBC)is autoimmune cholestatic liver disease of unknown etiology,refractory pruritus and severe hyperbilirubinemia often occur in some patients,currently,drug therapy is limited,late complications and poor prognosis,seriously affect the quality of life of patients.Non⁃bioartificial liver treatment model,which can temporarily replace part of liver function,are widely used in clinical practice.However,there are few studies on the application of non⁃biological artificial liver in the treatment of PBC patients.The research progress in recent years are summarized as follows.
作者
党富涛
唐映梅
谭绪
徐加敏
杨秋瑾
DANG Futao;TANG Yingmei;TAN Xu;XU Jiamin;YANG Qiujin(Department of Gastroenterology,the Second Affiliated Hospital of Kunming Medical University,Kunming 650000,China)
出处
《实用医学杂志》
CAS
北大核心
2020年第22期3153-3156,共4页
The Journal of Practical Medicine
基金
国家自然科学基金资助项目(编号:81660102,81360072)。
关键词
人工肝
胆管炎
肝衰竭
瘙痒
artificial liver
sclerosing cholangitis
liver failure
pruritus